Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi

Overview of attention for article published in Frontiers in oncology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Dimensions has found 2 publications that cite this research output.

Article in Cancers (March 2024)

Article in Reactions Weekly (July 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.